197 related articles for article (PubMed ID: 26443201)
1. Epigenetic silencing of the XAF1 gene is mediated by the loss of CTCF binding.
Victoria-Acosta G; Vazquez-Santillan K; Jimenez-Hernandez L; Muñoz-Galindo L; Maldonado V; Martinez-Ruiz GU; Melendez-Zajgla J
Sci Rep; 2015 Oct; 5():14838. PubMed ID: 26443201
[TBL] [Abstract][Full Text] [Related]
2. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.
Reich TR; Switzeny OJ; Renovanz M; Sommer C; Kaina B; Christmann M; Tomicic MT
Oncotarget; 2017 Feb; 8(9):15071-15084. PubMed ID: 28122345
[TBL] [Abstract][Full Text] [Related]
4. XAF1 is frequently methylated in human esophageal cancer.
Chen XY; He QY; Guo MZ
World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
Byun DS; Cho K; Ryu BK; Lee MG; Kang MJ; Kim HR; Chi SG
Cancer Res; 2003 Nov; 63(21):7068-75. PubMed ID: 14612497
[TBL] [Abstract][Full Text] [Related]
7. Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells.
Rodriguez BA; Weng YI; Liu TM; Zuo T; Hsu PY; Lin CH; Cheng AL; Cui H; Yan PS; Huang TH
Carcinogenesis; 2011 Jun; 32(6):812-21. PubMed ID: 21304052
[TBL] [Abstract][Full Text] [Related]
8. YY1 negatively regulates the XAF1 gene expression in prostate cancer.
Camacho-Moctezuma B; Quevedo-Castillo M; Melendez-Zajgla J; Aquino-Jarquin G; Martinez-Ruiz GU
Biochem Biophys Res Commun; 2019 Jan; 508(3):973-979. PubMed ID: 30551877
[TBL] [Abstract][Full Text] [Related]
9. Silencing of the XAF1 gene by promoter hypermethylation in cancer cells and reactivation to TRAIL-sensitization by IFN-beta.
Micali OC; Cheung HH; Plenchette S; Hurley SL; Liston P; LaCasse EC; Korneluk RG
BMC Cancer; 2007 Mar; 7():52. PubMed ID: 17376236
[TBL] [Abstract][Full Text] [Related]
10. [Frequent epigenetic inactivation of XAF1 by promotor hypermethylation in human colon cancers].
Jang JY; Kim HJ; Chi SG; Lee KY; Nam KD; Kim NH; Lee SK; Joo KR; Dong SH; Kim BH; Chang YW; Lee JI; Chang R
Korean J Gastroenterol; 2005 Apr; 45(4):285-93. PubMed ID: 15843754
[TBL] [Abstract][Full Text] [Related]
11. Frequent alteration of XAF1 in human colorectal cancers: implication for tumor cell resistance to apoptotic stresses.
Chung SK; Lee MG; Ryu BK; Lee JH; Han J; Byun DS; Chae KS; Lee KY; Jang JY; Kim HJ; Chi SG
Gastroenterology; 2007 Jun; 132(7):2459-77. PubMed ID: 17570219
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
[TBL] [Abstract][Full Text] [Related]
14. Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stresses.
Lee MG; Huh JS; Chung SK; Lee JH; Byun DS; Ryu BK; Kang MJ; Chae KS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
Oncogene; 2006 Sep; 25(42):5807-22. PubMed ID: 16909101
[TBL] [Abstract][Full Text] [Related]
15. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of the human p53 gene promoter by the CTCF transcription factor in transformed cell lines.
Soto-Reyes E; Recillas-Targa F
Oncogene; 2010 Apr; 29(15):2217-27. PubMed ID: 20101205
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modification of TLR4 promotes activation of NF-κB by regulating methyl-CpG-binding domain protein 2 and Sp1 in gastric cancer.
Kim TW; Lee SJ; Oh BM; Lee H; Uhm TG; Min JK; Park YJ; Yoon SR; Kim BY; Kim JW; Choe YK; Lee HG
Oncotarget; 2016 Jan; 7(4):4195-209. PubMed ID: 26675260
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth.
Vincent A; Hong SM; Hu C; Omura N; Young A; Kim H; Yu J; Knight S; Ayars M; Griffith M; Van Seuningen I; Maitra A; Goggins M
Oncotarget; 2014 May; 5(9):2575-87. PubMed ID: 24810906
[TBL] [Abstract][Full Text] [Related]
19. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
Eldholm V; Haugen A; Zienolddiny S
Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
[TBL] [Abstract][Full Text] [Related]
20. The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis.
Casalà C; Gil-Guiñón E; Ordóñez JL; Miguel-Queralt S; Rodríguez E; Galván P; Lavarino C; Munell F; de Alava E; Mora J; de Torres C
Carcinogenesis; 2013 Feb; 34(2):268-76. PubMed ID: 23108190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
